|
Feb 20
|
Bullish Cosmos Health Insiders Loaded Up On US$539.0k Of Stock
|
|
Feb 18
|
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1
|
|
Feb 11
|
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market
|
|
Feb 10
|
Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market
|
|
Feb 10
|
Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations
|
|
Aug 23
|
Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements
|
|
Jul 25
|
Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland
|
|
Jul 25
|
Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar
|
|
Jul 24
|
Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity
|
|
Jun 13
|
Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million
|
|
May 17
|
Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand
|
|
Apr 19
|
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
|
|
Mar 21
|
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
|
|
Mar 19
|
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
|
|
Mar 18
|
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
|
|
Jan 18
|
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
|
|
Dec 20
|
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
|
|
Dec 18
|
Cosmos Health Announces Open Market Stock Purchases by the CEO
|
|
Dec 8
|
Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York
|
|
Dec 7
|
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
|